1
|
Schmidt B, Roberts RS, Davis P, Doyle LW,
Barrington KJ, Ohlsson A, Solimano A and Tin W: Caffeine for Apnea
of Prematurity Trial Group. Caffeine therapy for apnea of
prematurity. N Engl J Med. 354:2112–2121. 2006.PubMed/NCBI View Article : Google Scholar
|
2
|
Pillekamp F, Hermann C, Keller T, von
Gontard A, Kribs A and Roth B: Factors influencing apnea and
bradycardia of prematurity-implications for neurodevelopment.
Neonatology. 91:155–161. 2007.PubMed/NCBI View Article : Google Scholar
|
3
|
Ducrocq S, Biran-Mucignat V, Boelle PY,
Lebas F, Baudon JJ and Gold F: Apnea of prematurity: Risk factors
and ambulatory treatment with caffeine citrate. Arch Pediatr.
13:1299–1304. 2006.PubMed/NCBI View Article : Google Scholar : (In French).
|
4
|
Martin RJ, Abu-Shaweesh JM and Baird TM:
Apnoea of prematurity. Paediatr Respir Rev. 5 (Suppl A):S377–S382.
2004.PubMed/NCBI View Article : Google Scholar
|
5
|
Siu A and James A: Apnea of prematurity
pharmacotherapy. US Pharm. 35:HS2–HS6. 2010.
|
6
|
Janvier A, Khairy M, Kokkotis A, Cormier
C, Messmer D and Barrington KJ: Apnea is associated with
neurodevelopmental impairment in very low birth weight infants. J
Perinatol. 24:763–768. 2004.PubMed/NCBI View Article : Google Scholar
|
7
|
Zhao J, Gonzalez F and Mu D: Apnea of
prematurity: From cause to treatment. Eur J Pediatr. 170:1097–1105.
2011.PubMed/NCBI View Article : Google Scholar
|
8
|
Henderson-Smart DJ and De Paoli AG:
Methylxanthine treatment for apnoea in preterm infants. Cochrane
Database Syst Rev: CD000140, 2010.
|
9
|
Pantalitschka T, Sievers J, Urschitz MS,
Herberts T, Reher C and Poets CF: Randomised crossover trial of
four nasal respiratory support systems for apnoea of prematurity in
very low birthweight infants. Arch Dis Child Fetal Neonatal Ed.
94:F245–F248. 2009.PubMed/NCBI View Article : Google Scholar
|
10
|
Lemyre B, Davis PG and de Paoli AG: Nasal
intermittent positive pressure ventilation (NIPPV) versus nasal
continuous positive airway pressure (NCPAP) for apnea of
prematurity. Cochrane Database Syst Rev: CD002272, 2002.
|
11
|
Koch G, Datta AN, Jost K, Schulzke SM, van
den Anker J and Pfister M: Caffeine citrate dosing adjustments to
assure stable caffeine concentrations in preterm neonates. J
Pediatr. 191:50–56.e1. 2017.PubMed/NCBI View Article : Google Scholar
|
12
|
Schoen K, Yu T, Stockmann C, Spigarelli MG
and Sherwin CM: Use of methylxanthine therapies for the treatment
and prevention of apnea of prematurity. Paediatr Drugs. 16:169–177.
2014.PubMed/NCBI View Article : Google Scholar
|
13
|
Brown MK and DiBlasi RM: Mechanical
ventilation of the premature neonate. Respir Care. 56:1298–1313.
2011.PubMed/NCBI View Article : Google Scholar
|
14
|
Reyes ZC, Claure N, Tauscher MK, D'Ugard
C, Vanbuskirk S and Bancalari E: Randomized, controlled trial
comparing synchronized intermittent mandatory ventilation and
synchronized intermittent mandatory ventilation plus pressure
support in preterm infants. Pediatrics. 118:1409–1417.
2006.PubMed/NCBI View Article : Google Scholar
|
15
|
Shi Y, Tang S, Zhao J and Shen J: A
prospective, randomized, controlled study of NIPPV versus nCPAP in
preterm and term infants with respiratory distress syndrome.
Pediatric Pulmonology. 49:673–678. 2014.PubMed/NCBI View Article : Google Scholar
|
16
|
Arlettaz R: Echocardiographic evaluation
of patent ductus arteriosus in preterm infants. Front Pediatr.
5(147)2017.PubMed/NCBI View Article : Google Scholar
|
17
|
Gien J and Kinsella JP: Pathogenesis and
treatment of bronchopulmonary dysplasia. Curr Opin Pediatr.
23:305–313. 2011.PubMed/NCBI View Article : Google Scholar
|
18
|
Coursey CA, Hollingsworth CL, Wriston C,
Beam C, Rice H and Bisset G III: Radiographic predictors of disease
severity in neonates and infants with necrotizing enterocolitis.
AJR Am J Roentgenol. 193:1408–1413. 2009.PubMed/NCBI View Article : Google Scholar
|
19
|
Fierson WM: AMERICAN ACADEMY OF PEDIATRICS
Section on Ophthalmology; AMERICAN ACADEMY OF OPHTHALMOLOGY;
AMERICAN ASSOCIATION FOR PEDIATRIC OPHTHALMOLOGY AND STRABISMUS;
AMERICAN ASSOCIATION OF CERTIFIED ORTHOPTISTS. Screening
examination of premature infants for retinopathy of prematurity.
Pediatrics. 142(e20183061)2018.PubMed/NCBI View Article : Google Scholar
|
20
|
O'Shea TM, Allred EN, Kuban KC, Hirtz D,
Specter B, Durfee S, Paneth N and Leviton A: ELGAN Study
Investigators. Intraventricular hemorrhage and developmental
outcomes at 24 months of age in extremely preterm infants. J Child
Neurol. 27:22–29. 2012.PubMed/NCBI View Article : Google Scholar
|
21
|
Stokowski LA: A primer on Apnea of
prematurity. Adv Neonatal Care. 5:155–170; quiz 171-174.
2005.PubMed/NCBI View Article : Google Scholar
|
22
|
Aranda JV, Beharry K, Valencia GB,
Natarajan G and Davis J: Caffeine impact on neonatal morbidities. J
Matern Fetal Neonatal Med. 23:20–23. 2010.PubMed/NCBI View Article : Google Scholar
|
23
|
Henderson-Smart DJ and Steer PA: Caffeine
versus theophylline for apnea in preterm infants. Cochrane Database
Syst Rev. 20(CD000273)2010.PubMed/NCBI View Article : Google Scholar
|
24
|
Mueni E, Opiyo N and English M: Caffeine
for the management of apnea in preterm infants. Int Health.
1:190–195. 2009.PubMed/NCBI View Article : Google Scholar
|
25
|
Donn SM and Sinha SK: Minimising
ventilator induced lung injury in preterm infants. Arch Dis Child
Fetal Neonatal Ed. 91:F226–F230. 2006.PubMed/NCBI View Article : Google Scholar
|
26
|
Rocha G, Soares P, Gonçalves A, Silva AI,
Almeida D, Figueiredo S, Pissarra S, Costa S, Soares H,
Flôr-de-Lima F and Guimarães H: Respiratory care for the ventilated
neonate. Can Respir J. 2018(7472964)2018.PubMed/NCBI View Article : Google Scholar
|
27
|
Garg S and Sinha S: Non-invasive
ventilation in premature infants: Based on evidence or habit. J
Clin Neonatol. 2:155–159. 2013.PubMed/NCBI View Article : Google Scholar
|
28
|
Deschamp A and Daftary A: A newborn infant
with oxygen desaturation during sleep. Chest. 151:e17–e20.
2017.PubMed/NCBI View Article : Google Scholar
|
29
|
Dobson NR and Patel RM: The role of
caffeine in non-invasive respiratory support. Clin Perinatol.
43:773–782. 2016.PubMed/NCBI View Article : Google Scholar
|
30
|
Abdel-Hady H, Nasef N, Shabaan AE and Nour
I: Caffeine therapy in preterm infants. World J Clin Pediatr.
4:81–93. 2015.PubMed/NCBI View Article : Google Scholar
|
31
|
Owen LS, Manley BJ, Davis PG and Doyle LW:
The evolution of modern respiratory care for preterm infants.
Lancet. 389:1649–1659. 2017.PubMed/NCBI View Article : Google Scholar
|
32
|
Kieran EA, Walsh H and O'Donnell CP:
Survey of nasal continuous positive airways pressure (NCPAP) and
nasal intermittent positive pressure ventilation (NIPPV) use in
Irish newborn nurseries. Arch Dis Child Fetal Neonatal Ed.
96(F156)2011.PubMed/NCBI View Article : Google Scholar
|
33
|
Lemyre B, Laughon M, Bose C and Davis PG:
Early nasal intermittent positive pressure ventilation (NIPPV)
versus early nasal continuous positive airway pressure (NCPAP) for
preterm infants. Cochrane Database Syst Rev.
12(CD005384)2016.PubMed/NCBI View Article : Google Scholar
|
34
|
Chakraborty M and Kotecha S: Pulmonary
surfactant in newborn infants and children. Breathe. 9:476–488.
2013.
|
35
|
Jobe AH: The new bronchopulmonary
dysplasia. Curr Opin Pediatr. 23:167–172. 2011.PubMed/NCBI View Article : Google Scholar
|
36
|
Muza RT: Central sleep apnoea-a clinical
review. J Thorac Dis. 7:930–937. 2015.PubMed/NCBI View Article : Google Scholar
|
37
|
Bancalari E: Caffeine for apnea of
prematurity. N Engl J Med. 354:2179–2181. 2006.
|
38
|
Kassim Z, Greenough A and Rafferty GF:
Effect of caffeine on respiratory muscle strength and lung function
in prematurely born, ventilated infants. Eur J Pediatr.
168:1491–1495. 2009.PubMed/NCBI View Article : Google Scholar
|
39
|
Clark RH, Bloom BT, Spitzer AR and
Gerstmann DR: Reported medication use in the neonatal intensive
care unit: Data from a large national data set. Pediatrics.
117:1979–1987. 2006.PubMed/NCBI View Article : Google Scholar
|
40
|
Stevenson DK: On the Caffeination of
Prematurity. N Engl J Med. 357:1967–1968. 2007.PubMed/NCBI View Article : Google Scholar
|
41
|
April J, Ekta P, Kyle C, Jreisat C,
Kampanatkosol R and Sajous C: Does early caffeine therapy effect
patent ductus arteriosus outcomes in very low birth weight infants?
Acad J Ped Neonatol. 4(555696)2017.
|
42
|
Lodha A, Entz R, Synnes A, Creighton D,
Yusuf K, Lapointe A, Yang J and Shah PS: investigators of the
Canadian Neonatal Network (CNN) and the Canadian Neonatal Follow-up
Network (CNFUN). Early caffeine administration and
neurodevelopmental outcomes in preterm infants. Pediatrics.
143(e20181348)2019.PubMed/NCBI View Article : Google Scholar
|
43
|
Bairam A, Uppari N, Mubayed S and Joseph
V: An overview on the respiratory stimulant effects of caffeine and
progesterone on response to hypoxia and apnea frequency in
developing rats. Adv Exp Med Biol. 860:211–220. 2015.PubMed/NCBI View Article : Google Scholar
|